ClinicalTrials.gg

Simcere Pharmaceutical Group Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 82 studies whose lead sponsor is Simcere Pharmaceutical Group Limited or one of 3 companies grouped under it. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Simcere Pharmaceutical Group with Jiangsu HengRui Medicine and Qilu Pharmaceutical →

Pipeline: 16 programs

Each counted once: 16 with a study Simcere Pharmaceutical Group Limited leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Simcere Pharmaceutical Group Limited’s own registered studies; Simcere Pharmaceutical Group Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Simcere Pharmaceutical Group Limited’s studies test, most open studies first — 24 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 14 more

Coming up

6 of Simcere Pharmaceutical Group Limited’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. 2J
  9. 1J
  10. A
  11. 1S
  12. 1O
  13. N

Add all 6 to your calendar (.ics) → With an account.

All 82 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1518%Recruiting 13 · Not yet recruiting 2
  • Under way, not recruiting79%
  • Completed2834%
  • Stopped early56%
  • Status unknown or other2733%

Phase

  • Phase 145
  • Phase 219
  • Phase 315
  • Phase 47

Where

  • China77
  • United States3

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 1222
  17. 23
  18. 24
  19. 25
  20. 926

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Simcere Pharmaceutical Group Limited.

  • Jiangsu Simcere Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    78 studies →
  • Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
    Acquired — became part of Simcere Pharmaceutical Group Limited, Sep 30, 2006 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Jiangsu Simcere Biologics Co., Ltd
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 50 of 82. Browse all 82 →